Sentences with phrase «new program in the future»

You can always easily register with a new program in the future.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

«New York State strongly opposes the Department of the Interior's National Outer Continental Shelf Oil and Gas Leasing Program as it poses an unacceptable threat to New York's ocean resources, to our economy and to the future of our children,» Cuomo said in announcing the exclusion request.

Airbus has a new senior management team coming on board in early 2019 and Myerson said that while it will be expected to address the future of the A380, investors will be focused more on the success of the A320 and A350 programs.

«No one knows exactly what this new program is going to look like in the future,» he said.

Before you know it you've described exciting new projects, enhanced benefit programs, opportunities for promotion due to potential expansions... lots of hopeful stuff that might happen in the future.

With the future of the travel ban still uncertain, applicants to the EB - 5 program are now rushing in, hoping to get approved before any new executive orders.

Even with local programs like the one being launched in New York, a future in which most workplaces are holding meetings in virtual reality and using holograms to work on a 3D model is still far off.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Leveraging the expertise of all of the partners, the goals of this program are to better position Ameren to meet its customers» future energy needs and expectations, create new jobs through these start - up companies and provide university students opportunities to be more engaged in the energy business.

An example of a program carrying out this work is Ryerson Futures — an accelerator program that works with startups based out of Toronto that moves past the idea of looking to Asia as only a source for investment, but rather for spaces of collaboration and growth in new markets.

OCAD University and the CFC Media Lab have partnered to launch a new and innovative Graduate Program in Digital Futures, with a part - time Graduate Diploma and full - time Master's Degrees.

SMB created world - class training programs in equities, options, futures and automated trading, so that new traders are given their best chance to succeed.

And then my follow - on, though, is with that strength in both your new program or wins of EMS and your packaging strength you're seeing, do we need to start to earmark some more money to support those or your current plans can support that growth for the foreseeable future?

Although there may be changes to the PSLF program in the future, any changes would only affect new borrowers.

Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.

In the fall of 1998 Candler School of Theology made a serious wager concerning its future: it launched a comprehensive new program in contextual educatioIn the fall of 1998 Candler School of Theology made a serious wager concerning its future: it launched a comprehensive new program in contextual educatioin contextual education.

Building on current programs and efficiencies that reduce water and energy use and greenhouse gas emissions, the new Bacardi Limited global platform, Good Spirited: Building a Sustainable Future, reinforces the Company's leadership in corporate social responsibility (CSR).

The team is excited to evolve the Kombucha program and plans to extend the on - tap program to all new Protein Bar locations to open in the future.

We spent a day in his foundation's new program — designed to develop future community leaders — to find out

Currently we have a few writers working on the site who cover different sports stories but very soon in future we are planning to start a «Writers Contribution Program» where we will hire new authors on voluntarily or paid basis depending on the experience.

I have asked our vice chancellor for student affairs, Dr. Kathy Cavins - Tull, to examine whether any new programs or procedures need to be implemented to curtail this type of behavior in the future.

We'd also like to create in the near future an «emergency» version of our program for struggling new mothers to watch.

Our new colors, new website and future enhancements to our programs, facilities and marketing and communications tools will reflect dynamic changes not only happening in our agency but in the park and recreation ind

Our camp programs are designed to help 6 to 11 year old youth see technology in a whole new light — as a medium for self - expression and as a means for shaping our future.

«When you consider the sum total of what NRG invests in New York each year, and plans to invest in the future, you can see that the Empire Zone program provides a fraction, albeit meaningful to us, back in tax relief,» said Meredith Moore, an NRG spokeswoman.

«We continue to invest in the development of downtown areas across Upstate New York, and with the launch of this innovative program, we will take our efforts a step further by enticing young graduates to make an investment in these communities and in their future,» Governor Cuomo said.

We look forward to working with the Governor, state agencies, and partners — both here in New York and across the nation — to help implement these programs, which will enable future generations to thrive.»

When it comes to higher education our SUNY 2020 and CUNY 2020 reinvestment and capital programs are working, we want to continue them for a second round the future of the economy is in STEM jobs, we should be incentivizing our education system to fill those openings we want to provide to the top ten percent of high school graduates full scholarships to any SUNY or CUNY school if they pursue a math of science career and agree to work in the state of New York for five years.

The Senate's budget, quietly released early on Saturday morning, keeps Cuomo's proposals to remove $ 485 million in funding for the City University of New York and to shift the growth of New York City's Medicaid program back to the city government, which will have a $ 180 million impact in the coming fiscal year and will increase in future years.

A joint press release said, «The plan would establish a new benefits system for future employees offering them the option to participate in either a traditional, but less generous, plan or a 401 (k) type program that is more flexible and permits for career growth.

It's going to be another interesting day in Albany as New York City Mayor Bill de Blasio is due to be questioned before the Senate Education Committee on mayoral control of city schools and the future of the program.

Represent NYC is a new weekly program in which local elected officials and candidates discuss the issues shaping the future of the city.

Question topics included the estimated time for completion of all of the Sandy recovery home rebuilding, the implementation of new flood maps, whether de Blasio's reported future endorsement of Hillary Clinton is tied to a longterm need for federal government assistance, whether in Secretary Castro's view the City could do better on any element of Sandy recovery efforts, communicating an increased sense of urgency to City agencies, significant variations in the reported number of Build It Back applicants, how the City will continue its increased rate of repairs, details on the construction firms used in the program and praise for developer Gerry Romski.

Contractors with the county must have NYS Certified Worker Training Programs that actually graduate workers as apprentices, thereby providing local workers with the education and skills training they need to succeed in construction trades now and in the future, while at the same time lessening the need for out - of - area workers on these jobs as local workers gain new skills.

But now that New York state has its own free state college tuition program, there are questions as to what role Say Yes will play in the future.

Election victories in New York by President Obama, Senator Kirsten Gillibrand, U.S. Representatives Bill Owens & Louise Slaughter, House candidates Sean Patrick Maloney and Dan Maffei and five high - profile State Senate candidates sent a clear message this week that New York voters want to stop special deals for the wealthy, invest for the future and protect important programs like Social Security, Medicare and Medicaid from harsh cuts.

Nevertheless, the WFP's overtures presented him with a new dilemma: His «New Democratic Party» platform includes a pledge not to raise taxes and a promise to enact legislation capping future increases in local property taxes that directly contradict WFP tenets which seek more funding for education and social welfare programs by raising taxes on the wealtnew dilemma: His «New Democratic Party» platform includes a pledge not to raise taxes and a promise to enact legislation capping future increases in local property taxes that directly contradict WFP tenets which seek more funding for education and social welfare programs by raising taxes on the wealtNew Democratic Party» platform includes a pledge not to raise taxes and a promise to enact legislation capping future increases in local property taxes that directly contradict WFP tenets which seek more funding for education and social welfare programs by raising taxes on the wealthy.

Residents have called for a new water source, lower state limits for PFOA in drinking water and a rigorous bio-monitoring program to similar incidents from happening in the future.

ALBANY — Education commissioner John King said Governor Andrew Cuomo and the Legislature should use the first year of New York's pre-kindergarten expansion to inform changes that might make the program more accessible to school districts in future years.

«Contractors with the county must have NYS Certified Worker Training Programs that actually graduate workers as apprentices, thereby providing local workers with the education and skills training they need to succeed in construction trades now and in the future, while at the same time lessening the need for out - of - area workers on these jobs as local workers gain new skills,» Poloncarz said in a statement.

The center will work with staff from SUNY Buffalo State, SUNY Alfred and Erie Community College to provide training in the advanced manufacturing and energy fields, including a program to support the future training needs of the New York Power Authority.

In conclusion, this new study identifies the cellular origin of Pik3ca - induced tumours and reveals that oncogenic Pik3ca activates a multipotent genetic program, setting the stage for future intratumoural heterogeneity at the earliest stage of tumor development.

Enhance your future potential by developing a career in biotech through the new 2 - year certificate program at ABC Community College.»

There is also concern that that the new Canadian federal government may cut or freeze educational funding, but Selby holds out hope that her program will hold the line and even expand in the future.

The Pew Environment Group's Global Ocean Legacy program has set its sights on two further massive protection areas in the near future: they hope to see New Zealand approve a 630,000 square km area in the Kermadec Islands later this year, and Australia protect 900,000 square km in the Coral Sea in 2012.

A few weeks ago, in writing a story about the Preparing Future Faculty program, I heard about changes in graduate student training and how those changes are affecting today's postdocs and new faculty.

In an online statement, SAMHSA said future work on the registry, including vetting new applications, would be moved in - house «to reconfigure its approach to identifying and disseminating evidence - based practice and programs.&raquIn an online statement, SAMHSA said future work on the registry, including vetting new applications, would be moved in - house «to reconfigure its approach to identifying and disseminating evidence - based practice and programs.&raquin - house «to reconfigure its approach to identifying and disseminating evidence - based practice and programs.»

«The scholars program has had an impressive impact on experimental neuroscience over its 30 - year existence — including advancing the careers of future Nobel Prize winners and members of the National Academy of Sciences,» says Thomas Jessell, a Columbia University neuroscientist in New York City and member of the McKnight Board of Directors.

Gregory Stock, who directs the program on medicine, technology, and society at the University of California at Los Angeles school of medicine, says in his new book, Redesigning Humans: Our Inevitable Genetic Future:» [T] he slippery slope has been used time and again to oppose all kinds of innovations.